Review



phospho dat polyclonal antibody  (PhosphoSolutions)


Bioz Verified Symbol PhosphoSolutions is a verified supplier
Bioz Manufacturer Symbol PhosphoSolutions manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    PhosphoSolutions phospho dat polyclonal antibody
    Phospho Dat Polyclonal Antibody, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+dat/Anti-Dopamine+Transporter+(Thr53)+Antibody/pmc13125265-87-14-19
    Average 96 stars, based on 16 article reviews
    phospho dat polyclonal antibody - by Bioz Stars, 2026-10
    96/100 stars

    Images

    Related Articles

    Saline:

    Article Title: Dopamine Dysregulation and Altered Responses to Drugs Affecting Dopaminergic Transmission in a New Dopamine Transporter Knockout (DAT-KO) Rat Model.
    Article Snippet: Under normal conditions, dopamine (DA) clearance after release largely depends on uptake by the DA transporter (DAT).. DAT expression/activity is reduced in some neuropsychiatric and neurological disorders.. Our aim was to characterize the behavioral, neurochemical and electrophysiological effects of eliminating DAT in a novel knockout rat model we generated using CRISPR/Cas9.

    Incubation:

    Article Title: Dopamine Dysregulation and Altered Responses to Drugs Affecting Dopaminergic Transmission in a New Dopamine Transporter Knockout (DAT-KO) Rat Model.
    Article Snippet: Under normal conditions, dopamine (DA) clearance after release largely depends on uptake by the DA transporter (DAT).. DAT expression/activity is reduced in some neuropsychiatric and neurological disorders.. Our aim was to characterize the behavioral, neurochemical and electrophysiological effects of eliminating DAT in a novel knockout rat model we generated using CRISPR/Cas9.

    Blocking Assay:

    Article Title: Dopamine Dysregulation and Altered Responses to Drugs Affecting Dopaminergic Transmission in a New Dopamine Transporter Knockout (DAT-KO) Rat Model.
    Article Snippet: Under normal conditions, dopamine (DA) clearance after release largely depends on uptake by the DA transporter (DAT).. DAT expression/activity is reduced in some neuropsychiatric and neurological disorders.. Our aim was to characterize the behavioral, neurochemical and electrophysiological effects of eliminating DAT in a novel knockout rat model we generated using CRISPR/Cas9.

    other:

    Article Title: Dopamine Dysregulation and Altered Responses to Drugs Affecting Dopaminergic Transmission in a New Dopamine Transporter Knockout (DAT-KO) Rat Model
    Article Snippet: Under normal conditions, dopamine (DA) clearance after release largely depends on uptake by the DA transporter (DAT).. DAT expression/activity is reduced in some neuropsychiatric and neurological disorders.. Our aim was to characterize behavioral, neurochemical and electrophysiological effects of eliminating DAT in a novel knockout rat model we generated using CRISPR/Cas9.



    Similar Products

    93
    Novus Biologicals mouse anti dat1 antibody
    Mouse Anti Dat1 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+dat/SLC6A3%2FDAT1+Antibody+(mAb16)/10__3390_slash_biomedicines14040927-55-4-10
    Average 93 stars, based on 1 article reviews
    mouse anti dat1 antibody - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    95
    Proteintech anti th
    Anti Th, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+dat/DAT+Antibody/pm41844629-245-0-12
    Average 95 stars, based on 1 article reviews
    anti th - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    97
    Proteintech dat 22524 1 ap
    Dat 22524 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+dat/beta+Actin+Monoclonal+antibody/pm41844629-245-8-12
    Average 97 stars, based on 1 article reviews
    dat 22524 1 ap - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology anti dat antibody
    ( A and B ) Representative Western blot ( A ) and quantification ( B ) of glycosylated and nonglycosylated dopamine transporter <t>(DAT)</t> in GBA1 L444P mutant dopaminergic neurons treated with increasing NALL concentrations. ( C and D ) Western blot ( C ) and quantification ( D ) of parkin expression in NALL-treated GBA1 L444P neurons. ( E – J ) Western blots and corresponding quantification of SYNJ1 redistribution from cytosolic (Cyto) to synaptic membrane (SM) fractions following NALL treatment in GBA1 L444P ( E and F ), GBA1 N370S ( G and H ), and parkin mutant ( I and J ) dopaminergic neurons. Synaptophysin (SYP) <t>and</t> <t>GAPDH</t> served as synaptic and cytosolic markers, respectively. ( K ) Scatter plot showing time constants of pHluorin fluorescence recovery following exocytosis in GBA1 L444P neurons. NALL-treated synapses (105.3 ± 5.8 s; n = 59 ROIs) recovered significantly faster than NT (133.2 ± 5.3 s; n = 89 ROIs) (Mann-Whitney test). Lines represent means ± SD. ( L ) Representative traces of pHluorin fluorescence intensity from 50 s before to 300 s after exocytosis in GBA1 L444P mutant neurons. For Western blots, β-III-tubulin and GAPDH served as loading controls ( n = 3 independent experiments). Data are expressed as mean fold-change relative to 0 mM (DMSO) or nontreated (NT) groups. Statistical significance was determined by 1-way ANOVA ( B and D ), Student’s t test ( F , H , and J ), or Mann-Whitney test ( K ). Data represent mean ± SEM, except in K (mean ± SD). * P < 0.05, ** P < 0.01, *** P < 0.005, and **** P < 0.001.
    Anti Dat Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+dat/DAT+Antibody/pmc12948429-183-54-56
    Average 94 stars, based on 1 article reviews
    anti dat antibody - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    95
    Proteintech rabbit
    ( A and B ) Representative Western blot ( A ) and quantification ( B ) of glycosylated and nonglycosylated dopamine transporter <t>(DAT)</t> in GBA1 L444P mutant dopaminergic neurons treated with increasing NALL concentrations. ( C and D ) Western blot ( C ) and quantification ( D ) of parkin expression in NALL-treated GBA1 L444P neurons. ( E – J ) Western blots and corresponding quantification of SYNJ1 redistribution from cytosolic (Cyto) to synaptic membrane (SM) fractions following NALL treatment in GBA1 L444P ( E and F ), GBA1 N370S ( G and H ), and parkin mutant ( I and J ) dopaminergic neurons. Synaptophysin (SYP) <t>and</t> <t>GAPDH</t> served as synaptic and cytosolic markers, respectively. ( K ) Scatter plot showing time constants of pHluorin fluorescence recovery following exocytosis in GBA1 L444P neurons. NALL-treated synapses (105.3 ± 5.8 s; n = 59 ROIs) recovered significantly faster than NT (133.2 ± 5.3 s; n = 89 ROIs) (Mann-Whitney test). Lines represent means ± SD. ( L ) Representative traces of pHluorin fluorescence intensity from 50 s before to 300 s after exocytosis in GBA1 L444P mutant neurons. For Western blots, β-III-tubulin and GAPDH served as loading controls ( n = 3 independent experiments). Data are expressed as mean fold-change relative to 0 mM (DMSO) or nontreated (NT) groups. Statistical significance was determined by 1-way ANOVA ( B and D ), Student’s t test ( F , H , and J ), or Mann-Whitney test ( K ). Data represent mean ± SEM, except in K (mean ± SD). * P < 0.05, ** P < 0.01, *** P < 0.005, and **** P < 0.001.
    Rabbit, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+dat/DAT+Antibody/pmc12296429-3-2-6
    Average 95 stars, based on 1 article reviews
    rabbit - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    Proteintech 22524 1 ap
    ( A and B ) Representative Western blot ( A ) and quantification ( B ) of glycosylated and nonglycosylated dopamine transporter <t>(DAT)</t> in GBA1 L444P mutant dopaminergic neurons treated with increasing NALL concentrations. ( C and D ) Western blot ( C ) and quantification ( D ) of parkin expression in NALL-treated GBA1 L444P neurons. ( E – J ) Western blots and corresponding quantification of SYNJ1 redistribution from cytosolic (Cyto) to synaptic membrane (SM) fractions following NALL treatment in GBA1 L444P ( E and F ), GBA1 N370S ( G and H ), and parkin mutant ( I and J ) dopaminergic neurons. Synaptophysin (SYP) <t>and</t> <t>GAPDH</t> served as synaptic and cytosolic markers, respectively. ( K ) Scatter plot showing time constants of pHluorin fluorescence recovery following exocytosis in GBA1 L444P neurons. NALL-treated synapses (105.3 ± 5.8 s; n = 59 ROIs) recovered significantly faster than NT (133.2 ± 5.3 s; n = 89 ROIs) (Mann-Whitney test). Lines represent means ± SD. ( L ) Representative traces of pHluorin fluorescence intensity from 50 s before to 300 s after exocytosis in GBA1 L444P mutant neurons. For Western blots, β-III-tubulin and GAPDH served as loading controls ( n = 3 independent experiments). Data are expressed as mean fold-change relative to 0 mM (DMSO) or nontreated (NT) groups. Statistical significance was determined by 1-way ANOVA ( B and D ), Student’s t test ( F , H , and J ), or Mann-Whitney test ( K ). Data represent mean ± SEM, except in K (mean ± SD). * P < 0.05, ** P < 0.01, *** P < 0.005, and **** P < 0.001.
    22524 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+dat/DAT+Antibody/pmc12296429-3-8-6
    Average 95 stars, based on 1 article reviews
    22524 1 ap - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    96
    PhosphoSolutions phospho dat polyclonal antibody
    ( A and B ) Representative Western blot ( A ) and quantification ( B ) of glycosylated and nonglycosylated dopamine transporter <t>(DAT)</t> in GBA1 L444P mutant dopaminergic neurons treated with increasing NALL concentrations. ( C and D ) Western blot ( C ) and quantification ( D ) of parkin expression in NALL-treated GBA1 L444P neurons. ( E – J ) Western blots and corresponding quantification of SYNJ1 redistribution from cytosolic (Cyto) to synaptic membrane (SM) fractions following NALL treatment in GBA1 L444P ( E and F ), GBA1 N370S ( G and H ), and parkin mutant ( I and J ) dopaminergic neurons. Synaptophysin (SYP) <t>and</t> <t>GAPDH</t> served as synaptic and cytosolic markers, respectively. ( K ) Scatter plot showing time constants of pHluorin fluorescence recovery following exocytosis in GBA1 L444P neurons. NALL-treated synapses (105.3 ± 5.8 s; n = 59 ROIs) recovered significantly faster than NT (133.2 ± 5.3 s; n = 89 ROIs) (Mann-Whitney test). Lines represent means ± SD. ( L ) Representative traces of pHluorin fluorescence intensity from 50 s before to 300 s after exocytosis in GBA1 L444P mutant neurons. For Western blots, β-III-tubulin and GAPDH served as loading controls ( n = 3 independent experiments). Data are expressed as mean fold-change relative to 0 mM (DMSO) or nontreated (NT) groups. Statistical significance was determined by 1-way ANOVA ( B and D ), Student’s t test ( F , H , and J ), or Mann-Whitney test ( K ). Data represent mean ± SEM, except in K (mean ± SD). * P < 0.05, ** P < 0.01, *** P < 0.005, and **** P < 0.001.
    Phospho Dat Polyclonal Antibody, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+dat/Anti-Dopamine+Transporter+(Thr53)+Antibody/pmc13125265-87-14-19
    Average 96 stars, based on 1 article reviews
    phospho dat polyclonal antibody - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology sc32259
    ( A and B ) Representative Western blot ( A ) and quantification ( B ) of glycosylated and nonglycosylated dopamine transporter <t>(DAT)</t> in GBA1 L444P mutant dopaminergic neurons treated with increasing NALL concentrations. ( C and D ) Western blot ( C ) and quantification ( D ) of parkin expression in NALL-treated GBA1 L444P neurons. ( E – J ) Western blots and corresponding quantification of SYNJ1 redistribution from cytosolic (Cyto) to synaptic membrane (SM) fractions following NALL treatment in GBA1 L444P ( E and F ), GBA1 N370S ( G and H ), and parkin mutant ( I and J ) dopaminergic neurons. Synaptophysin (SYP) <t>and</t> <t>GAPDH</t> served as synaptic and cytosolic markers, respectively. ( K ) Scatter plot showing time constants of pHluorin fluorescence recovery following exocytosis in GBA1 L444P neurons. NALL-treated synapses (105.3 ± 5.8 s; n = 59 ROIs) recovered significantly faster than NT (133.2 ± 5.3 s; n = 89 ROIs) (Mann-Whitney test). Lines represent means ± SD. ( L ) Representative traces of pHluorin fluorescence intensity from 50 s before to 300 s after exocytosis in GBA1 L444P mutant neurons. For Western blots, β-III-tubulin and GAPDH served as loading controls ( n = 3 independent experiments). Data are expressed as mean fold-change relative to 0 mM (DMSO) or nontreated (NT) groups. Statistical significance was determined by 1-way ANOVA ( B and D ), Student’s t test ( F , H , and J ), or Mann-Whitney test ( K ). Data represent mean ± SEM, except in K (mean ± SD). * P < 0.05, ** P < 0.01, *** P < 0.005, and **** P < 0.001.
    Sc32259, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+dat/DAT+Antibody/pmc12907166-1-12-6
    Average 94 stars, based on 1 article reviews
    sc32259 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    ( A and B ) Representative Western blot ( A ) and quantification ( B ) of glycosylated and nonglycosylated dopamine transporter (DAT) in GBA1 L444P mutant dopaminergic neurons treated with increasing NALL concentrations. ( C and D ) Western blot ( C ) and quantification ( D ) of parkin expression in NALL-treated GBA1 L444P neurons. ( E – J ) Western blots and corresponding quantification of SYNJ1 redistribution from cytosolic (Cyto) to synaptic membrane (SM) fractions following NALL treatment in GBA1 L444P ( E and F ), GBA1 N370S ( G and H ), and parkin mutant ( I and J ) dopaminergic neurons. Synaptophysin (SYP) and GAPDH served as synaptic and cytosolic markers, respectively. ( K ) Scatter plot showing time constants of pHluorin fluorescence recovery following exocytosis in GBA1 L444P neurons. NALL-treated synapses (105.3 ± 5.8 s; n = 59 ROIs) recovered significantly faster than NT (133.2 ± 5.3 s; n = 89 ROIs) (Mann-Whitney test). Lines represent means ± SD. ( L ) Representative traces of pHluorin fluorescence intensity from 50 s before to 300 s after exocytosis in GBA1 L444P mutant neurons. For Western blots, β-III-tubulin and GAPDH served as loading controls ( n = 3 independent experiments). Data are expressed as mean fold-change relative to 0 mM (DMSO) or nontreated (NT) groups. Statistical significance was determined by 1-way ANOVA ( B and D ), Student’s t test ( F , H , and J ), or Mann-Whitney test ( K ). Data represent mean ± SEM, except in K (mean ± SD). * P < 0.05, ** P < 0.01, *** P < 0.005, and **** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: N-acetyl- l -leucine lowers α -synuclein levels and improves synaptic function in Parkinson’s disease models

    doi: 10.1172/JCI196137

    Figure Lengend Snippet: ( A and B ) Representative Western blot ( A ) and quantification ( B ) of glycosylated and nonglycosylated dopamine transporter (DAT) in GBA1 L444P mutant dopaminergic neurons treated with increasing NALL concentrations. ( C and D ) Western blot ( C ) and quantification ( D ) of parkin expression in NALL-treated GBA1 L444P neurons. ( E – J ) Western blots and corresponding quantification of SYNJ1 redistribution from cytosolic (Cyto) to synaptic membrane (SM) fractions following NALL treatment in GBA1 L444P ( E and F ), GBA1 N370S ( G and H ), and parkin mutant ( I and J ) dopaminergic neurons. Synaptophysin (SYP) and GAPDH served as synaptic and cytosolic markers, respectively. ( K ) Scatter plot showing time constants of pHluorin fluorescence recovery following exocytosis in GBA1 L444P neurons. NALL-treated synapses (105.3 ± 5.8 s; n = 59 ROIs) recovered significantly faster than NT (133.2 ± 5.3 s; n = 89 ROIs) (Mann-Whitney test). Lines represent means ± SD. ( L ) Representative traces of pHluorin fluorescence intensity from 50 s before to 300 s after exocytosis in GBA1 L444P mutant neurons. For Western blots, β-III-tubulin and GAPDH served as loading controls ( n = 3 independent experiments). Data are expressed as mean fold-change relative to 0 mM (DMSO) or nontreated (NT) groups. Statistical significance was determined by 1-way ANOVA ( B and D ), Student’s t test ( F , H , and J ), or Mann-Whitney test ( K ). Data represent mean ± SEM, except in K (mean ± SD). * P < 0.05, ** P < 0.01, *** P < 0.005, and **** P < 0.001.

    Article Snippet: Antibodies used for immunoblotting include anti-pS129-syn antibody (Cell Signaling Technology: 23706S), anti-SYP antibody (MilliporeSigma: ab9272), anti-α-syn antibody (Santa Cruz Biotechnology: sc-7011-R), anti-β-III-tubulin antibody (BioLegend: 801202), anti-SYNJ1 antibody (LsBio: 65169), anti-parkin antibody (Santa Cruz Biotechnology: sc-32282), anti-HTRA1 (R&D Systems: MAB2916), anti-HTRA1 (Proteintech: 55011-1-AP), anti-caspase 3 (Cell Signaling Technology: 9662), anti-cleaved caspase-3 (Cell Signaling Technology: 9661S), anti-DAT antibody (Santa Cruz Biotechnology: sc-32259), anti-GAPDH antibody (MilliporeSigma: MAB374), Goat Anti-Rat IgG (H+L) (Peroxidase AffiniPure: 112-035-062), Goat Anti-Rabbit IgG (H+L) (Peroxidase-AffiniPure: 111-035-144), and Goat Anti-Mouse IgG (H+L) (Peroxidase-AffiniPure: 115-035-146).

    Techniques: Western Blot, Mutagenesis, Expressing, Membrane, Fluorescence, MANN-WHITNEY